ic 831423 has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourgondiƫn, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
Choay, J; Fareed, J; Lormeau, JC; Petitou, M; Samama, M; Walenga, JM | 2 |
3 other study(ies) available for ic 831423 and Disease Models, Animal
Article | Year |
---|---|
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.
Topics: Animals; Antithrombin III; Disease Models, Animal; Dose-Response Relationship, Drug; Factor X; Factor Xa; Heparin; Male; Oligosaccharides; Prothrombin; Rabbits; Thromboplastin; Thrombosis | 1987 |
Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model.
Topics: Animals; Disease Models, Animal; Factor X; Factor Xa; Heparin; Humans; Injections, Intravenous; Male; Oligosaccharides; Prothrombin; Rabbits; Thrombin; Thrombosis | 1986 |